Back to Search Start Over

IgG4 serum levels are not elevated in cases of Post-COVID syndrome

Authors :
Jonas Abel
Annika J. Walter
Vivian Glück
Clara L. Magnus
Thomas Glück
Philipp Schuster
Stefan Blaas
Ida Montanari
Michael Koller
Arno Mohr
Thilo Hinterberger
Bernd Salzberger
Kerstin Renner
Matthias Mack
Robert Bals
Tina Schmidt
Verena Klemis
Martina Sester
Romina Kardashi
Katja de With
Thomas H. Loew
Maximilian Malfertheiner
Michael Pfeifer
André Gessner
Barbara Schmidt
Daniel Schmalenberger
David Peterhoff
Publication Year :
2023
Publisher :
Cold Spring Harbor Laboratory, 2023.

Abstract

Recently, unexpectedly high virus-specific IgG4 levels were reported after more than two mRNA vaccinations. Class switch towards IgG4 occurs after long-term antigen exposure, downregulates immune responses and is associated with several autoimmune diseases.Here, we examined differences in antigen-specific IgG subtypes in serum samples from 64 Post-COVID patients and an equally sized cohort of convalescent controls.In both cohorts, the relative amounts of spike protein-specific IgG subtypes were comparable. IgG1 was the most frequent, followed by IgG3, IgG2, and IgG4. A difference between cohorts was observed only for IgG2, which was significantly lower in the Post-COVID cohort. Further analysis of the reactive IgG4 revealed a small but significant difference for the spike protein receptor-binding domain but not for the spike ectodomain.Since the total IgG4 levels are very low, we do not expect a biologically relevant role in Post-COVID syndrome. However, reduced virus-specific IgG2 levels could contribute to the persistence of SARS-CoV-2, causing chronic inflammation in the setting of Post-COVID syndrome.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........79bb6287130c957fbecb71704a0df1b7
Full Text :
https://doi.org/10.1101/2023.03.01.530454